Texas Childrens Cancer and Hematology Center

Houston, Texas 77098

1 studies enrolling now · 7 studies all time

What they study most

Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Acute Undifferentiated Leukemia, Aplastic Anemia, B-Cell Acute Lymphoblastic Leukemia, CNS Tumors, INI1-negative Tumors, Malignant Rhabdoid Tumor of Ovary, Mixed Phenotype Acute Leukemia, Pediatric AML, Relapsed/Refractory Leukemias

Studies at this site

• UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML — Recruiting now
• Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options — Running, not enrolling
• Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients — Running, not enrolling
• A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD) — Completed
• A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia — Completed
• EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma — Completed
• A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia — Completed